Rise Advisors, LLC Ptc Therapeutics, Inc. Transaction History
Rise Advisors, LLC
- $220 Million
- Q1 2025
A detailed history of Rise Advisors, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 184 shares of PTCT stock, worth $8,502. This represents 0.0% of its overall portfolio holdings.
Number of Shares
184Holding current value
$8,502% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
283Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$359 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$346 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$251 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$250 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.31B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...